Form D · Biotechnology

Amydis, Inc.

Los Angeles, CA · CIK 0001924488

Offering snapshot reported Dec 28, 2023 · SEC filing

Reported sold
$3M
Offering amount: $6M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 14, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 28, 2023Initial$3,000,000No comparison1SEC filing
Dec 29, 2022Initial$5,999,991No comparison2SEC filing
Apr 22, 2022Initial$5,685,732No comparison14SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-500947
Offering of convertible promissory notes and the underlying equity securities issuable upon such conversion.

Source: Form D, filed Dec 28, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christine Aylward Director
Faith Charles Director
James Khodabakhsh Director
Stella Sarraf Director, Executive
Jerre L. Stead Director
Jack Thrift, Cpa Executive
Mervyn Turner Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1901 Avenue Of The Stars Suite 200
Los Angeles, CA, 90067
Phone: 310-229-5710